OA10236A - 1,5 Benzodiazepine derivatives having cck and/or gastrin antagonistic activity - Google Patents

1,5 Benzodiazepine derivatives having cck and/or gastrin antagonistic activity Download PDF

Info

Publication number
OA10236A
OA10236A OA60721A OA60721A OA10236A OA 10236 A OA10236 A OA 10236A OA 60721 A OA60721 A OA 60721A OA 60721 A OA60721 A OA 60721A OA 10236 A OA10236 A OA 10236A
Authority
OA
OAPI
Prior art keywords
formula
compound
compounds
phenyl
cck
Prior art date
Application number
OA60721A
Other languages
English (en)
Inventor
Finch Harry
Shah Pritom
Carr Robin Arthur Ellis
Original Assignee
Glaxo Wellcome Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB939307833A external-priority patent/GB9307833D0/en
Priority claimed from GB9406037A external-priority patent/GB9406037D0/en
Application filed by Glaxo Wellcome Inc filed Critical Glaxo Wellcome Inc
Publication of OA10236A publication Critical patent/OA10236A/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/08—Tripeptides
    • C07K5/0821—Tripeptides with the first amino acid being heterocyclic, e.g. His, Pro, Trp
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/02—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link
    • C07K5/0202—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link containing the structure -NH-X-X-C(=0)-, X being an optionally substituted carbon atom or a heteroatom, e.g. beta-amino acids
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/02—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link
    • C07K5/0207—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link containing the structure -NH-(X)4-C(=0), e.g. 'isosters', replacing two amino acids
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/06—Dipeptides
    • C07K5/06139—Dipeptides with the first amino acid being heterocyclic
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/06—Dipeptides
    • C07K5/06191—Dipeptides containing heteroatoms different from O, S, or N
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/08—Tripeptides
    • C07K5/0827—Tripeptides containing heteroatoms different from O, S, or N
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biochemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
OA60721A 1993-04-15 1995-10-21 1,5 Benzodiazepine derivatives having cck and/or gastrin antagonistic activity OA10236A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB939307833A GB9307833D0 (en) 1993-04-15 1993-04-15 Modulators of cholecystokinin and gastrin
GB9406037A GB9406037D0 (en) 1994-03-29 1994-03-29 1,5 Benzodiazepine derivatives

Publications (1)

Publication Number Publication Date
OA10236A true OA10236A (en) 1997-10-07

Family

ID=26302765

Family Applications (1)

Application Number Title Priority Date Filing Date
OA60721A OA10236A (en) 1993-04-15 1995-10-21 1,5 Benzodiazepine derivatives having cck and/or gastrin antagonistic activity

Country Status (14)

Country Link
EP (1) EP0694040A1 (zh)
JP (1) JPH08508743A (zh)
CN (1) CN1120845A (zh)
AU (1) AU688316B2 (zh)
CA (1) CA2158972A1 (zh)
CZ (1) CZ267695A3 (zh)
FI (1) FI954852A0 (zh)
HU (1) HUT74091A (zh)
NO (1) NO954091L (zh)
NZ (1) NZ265271A (zh)
OA (1) OA10236A (zh)
PL (1) PL311083A1 (zh)
SK (1) SK125495A3 (zh)
WO (1) WO1994024151A1 (zh)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2173167T3 (es) * 1993-12-28 2002-10-16 Shionogi & Co Derivados de benzodiazepina.
PT945445E (pt) * 1996-12-10 2004-01-30 Zeria Pharm Co Ltd Derivados de 1,5-benzodiazepina
US6444849B1 (en) 1997-06-25 2002-09-03 Mitsubishi Chemical Corporation Amide derivatives
JP2000026434A (ja) 1998-06-05 2000-01-25 Zeria Pharmaceut Co Ltd 新規１，５−ベンゾジアゼピン誘導体
WO2000037434A1 (fr) * 1998-12-22 2000-06-29 Mitsubishi Chemical Corporation Derives d'amide
GB201414116D0 (en) 2014-08-08 2014-09-24 Trio Medicines Ltd Benzodiazepine derivatives
GB201513979D0 (en) 2015-08-07 2015-09-23 Trio Medicines Ltd Synthesis of benzodiazepine derivatives
KR20220150270A (ko) 2019-10-07 2022-11-10 칼리오페, 인크. Gpr119 효능제

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2641280B1 (fr) * 1988-12-29 1994-01-21 Roussel Uclaf Nouveaux derives de la 2,4-dioxo 2,3,4,5-tetrahydro 1h-1,5-benzodiazepine, leur procede de preparation et leur application comme medicaments
FR2659653B1 (fr) * 1990-03-13 1992-05-22 Rhone Poulenc Sante Derives de l'uree, leur preparation et les medicaments les contenant.
US5206234A (en) * 1990-10-22 1993-04-27 Merck & Co., Inc. Benzolactam analogs as antagonists of cck
GEP20001968B (en) * 1992-01-21 2000-03-05 Glaxo Spa Arilthio Compounds as Antibacterial and Antiviral Agents

Also Published As

Publication number Publication date
NO954091L (no) 1995-12-13
FI954852A (fi) 1995-10-12
HUT74091A (en) 1996-11-28
NO954091D0 (no) 1995-10-13
CA2158972A1 (en) 1994-10-27
AU688316B2 (en) 1998-03-12
NZ265271A (en) 1997-06-24
FI954852A0 (fi) 1995-10-12
SK125495A3 (en) 1996-06-05
WO1994024151A1 (en) 1994-10-27
EP0694040A1 (en) 1996-01-31
JPH08508743A (ja) 1996-09-17
AU6567594A (en) 1994-11-08
HU9502977D0 (en) 1995-12-28
CZ267695A3 (en) 1996-04-17
CN1120845A (zh) 1996-04-17
PL311083A1 (en) 1996-02-05

Similar Documents

Publication Publication Date Title
US5585376A (en) 1,5-benzodiazepine derivatives having CCK and/or gastrin antagonistic activity
AU640113B2 (en) Benzodiazepine analogs
AU679085B2 (en) Benzodiazepine analogs
US5618812A (en) Benzodiazepine derivatives
US5324726A (en) Benzodiazepine analogs
US5681833A (en) Benzodiazepine derivatives
US4820834A (en) Benzodiazepine analogs
IE904560A1 (en) New benzodiazepine analogs
US5302591A (en) Benzodiazepine derivatives
EP0490590A1 (en) New benzodiazepine analogs
EP0169392A2 (en) Triazolobenzodiazepines and pharmaceutical compositions containing them
AU697349B2 (en) CCK or gastrin modulating 5-heterocyclic-1,5-benzodiazepines
CA2066083C (en) Benzodiazepine analogs as cholecystokinin antagonists
CA2065715A1 (en) Cholecystokinin antagonists
US5686449A (en) 1,5-benzodiazepines useful as gastrinor CCK-antagonists
IL110366A (en) History of 1,5-benzodiazepines, their preparation and pharmaceutical preparations containing them
OA10236A (en) 1,5 Benzodiazepine derivatives having cck and/or gastrin antagonistic activity
JPH0680650A (ja) コレシストキニン拮抗薬
US5641775A (en) 3-phenylureido-1,5-benzodiazepine-diones useful as gastrin or antagonists
EP0272868A1 (en) 1,4-Benzodiazepines with 6-membered heterocyclic rings
GB2266528A (en) Benzodiazepine derivatives